Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Zwerina

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Zeitschrift Fur Rheumatologie|March 1, 2008
[Churg-Strauss syndrome]J Zwerina
Der Orthopade|June 19, 2010
[Osteoarthritis in hereditary metabolic diseases]J Zwerina, T Dallos
Zeitschrift Fur Rheumatologie|July 23, 2015
[Hemochromatosis]B Oppl, J Zwerina
Zeitschrift Fur Rheumatologie|March 20, 2010
[Osteoarthritis in hereditary metabolic diseases]J Zwerina, T Dallos
Annals of the Rheumatic Diseases|September 11, 2007
The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritisG Schett, J Zwerina, G Firestein
Allergy|January 22, 2013
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the artA Vaglio, C Buzio, J Zwerina
Zeitschrift Fur Rheumatologie|April 23, 2009
[Mesenchymal stem cells in arthritis]J-P David, J Zwerina, G Schett
Zeitschrift Fur Rheumatologie|April 5, 2013
[Pachydermodactyly]R Kariotis, E Vrtíková, M Hapčová, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 19, 2015
Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide studyW Brozek, B Reichardt, J Zwerina, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 14, 2017
Use of proton pump inhibitors and mortality after hip fracture in a nationwide studyW Brozek, B Reichardt, J Zwerina, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Zeitschrift Fur Rheumatologie|March 1, 2008
[Churg-Strauss syndrome]J Zwerina
Der Orthopade|June 19, 2010
[Osteoarthritis in hereditary metabolic diseases]J Zwerina, T Dallos
Zeitschrift Fur Rheumatologie|July 23, 2015
[Hemochromatosis]B Oppl, J Zwerina
Zeitschrift Fur Rheumatologie|March 20, 2010
[Osteoarthritis in hereditary metabolic diseases]J Zwerina, T Dallos
Annals of the Rheumatic Diseases|September 11, 2007
The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritisG Schett, J Zwerina, G Firestein
Allergy|January 22, 2013
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the artA Vaglio, C Buzio, J Zwerina
Zeitschrift Fur Rheumatologie|April 23, 2009
[Mesenchymal stem cells in arthritis]J-P David, J Zwerina, G Schett
Zeitschrift Fur Rheumatologie|April 5, 2013
[Pachydermodactyly]R Kariotis, E Vrtíková, M Hapčová, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 19, 2015
Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide studyW Brozek, B Reichardt, J Zwerina, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 14, 2017
Use of proton pump inhibitors and mortality after hip fracture in a nationwide studyW Brozek, B Reichardt, J Zwerina, et al.
Pageof 3